Reductions in Complex Mismatch Negativity to Extra Tone Gestalt Pattern Deviance in First-Episode Schizophrenia
Dean F Salisbury1, Brian A Coffman1, Sarah M Haigh1
1Clinical Neurophysiology Research Laboratory, Department of Psychiatry, Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Complex mismatch negativity (cMMN) shows significant reduction in first episode schizophrenia spectrum (FESz) individuals, unlike simple MMN. This auditory processing deficit correlates with social functioning, suggesting cMMN as an early schizophrenia biomarker.
Area of Science:
- Neuroscience
- Psychiatry
- Auditory Processing
Background:
- Simple mismatch negativity (sMMN) is reduced in chronic schizophrenia but less so in first episode schizophrenia spectrum (FESz).
- Complex mismatch negativity (cMMN), reflecting acoustic pattern analysis, is reduced in schizophrenia but understudied in FESz.
- cMMN's computational demands may reveal sensitive auditory processing deficits early in psychosis.
Purpose of the Study:
- To investigate cMMN in FESz individuals compared to healthy controls (HC).
- To determine if cMMN is a sensitive biomarker for early schizophrenia pathophysiology and its relation to social functioning.
Main Methods:
- Twenty-two FESz individuals and 22 HC underwent auditory tasks assessing sMMN (pitch, duration deviants) and cMMN (extra tone deviant).
- Data analysis focused on MMN amplitude differences between FESz and HC groups.
Main Results:
- FESz individuals showed no significant reduction in pitch- or duration-deviant sMMN.
- A large reduction in extra-tone cMMN was observed in FESz individuals compared to HC.
- Reduced cMMN amplitude in FESz was associated with poorer social functioning.
Conclusions:
- Impaired complex auditory pattern processing (cMMN) is evident early in schizophrenia spectrum disorders.
- cMMN serves as a sensitive indicator of early pathology and its impact on social functioning.
- Further research in at-risk populations is needed to validate cMMN as a prodromal schizophrenia biomarker.
More Related Videos
13:08Measurement of Fronto-limbic Activity Using an Emotional Oddball Task in Children with Familial High Risk for Schizophrenia
Published on: December 2, 2015
12:00Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
Related Concept Videos
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychological and Sociocultural Causes of Schizophrenia
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...
